Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

FOLD
Amicus Therapeutics, Inc
stock NASDAQ

Market Open
Jul 10, 2025 3:02:38 PM EDT
6.29USD-2.025%(-0.13)2,405,365
6.29Bid   6.30Ask   0.01Spread
Pre-market
Jul 10, 2025 9:02:30 AM EDT
6.55USD+2.025%(+0.13)5,244
After-hours
Jul 9, 2025 4:00:30 PM EDT
6.42USD-0.078%(-0.01)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
open chart   
Market Cap
1.94B
CEO
John Crowley
Headquarters
Cranbury, New Jersey, USA
Industry
Biotechnology
Next Earnings
Jul 31, 2025 (21d)
Related
BMRNSHPGBIIBGSKNVOPLXESPRLXRXXLV
FOLD Stats
Avg. Vol. 10 Day
4,969,915
Avg. Vol. 30 Day
5,292,758
Employees
325
Market Cap
1,940,057,578
Shares Out.
307,930,984
On/Off Exchange
52%/48%
6 Month Beta
0.64
1 Year Beta
0.73
2 Year Beta
0.81
3 Year Beta
0.83
52 Week Low
5.51
52 Week High
12.65
SMA50
6.18
SMA200
8.72
1 Week
+3.28%
1 Month
+3.12%
3 Month
-3.22%
6 Month
-30.15%
1 Year
-39.01%
2 Year
-47.97%
5 Year
-59.43%
Profile
amicus therapeutics is a global, patient-centric biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. we have a unique set of platform technologies and medicines in development for patients living with the lysosomal storage disorders fabry disease and pompe disease and we are committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for these and other rare diseases. the needs of patients in the rare disease community are at the center of our inventive science, our commercial organization, and our clinical programs. our goal throughout all levels of the organization is to make a meaningful difference in the lives of these patients and their caregivers. several opportunities are available to join our team as we build a leading global biotechnology company focused on rare metabolic diseases. our amicus footprint spans 27 countries including our g

FOLD Stock Summary

Amicus Therapeutics, Inc (NASDAQ:FOLD) stock price today is $6.29, and today's volume is 2,405,365. FOLD is down -2.025% today. The 30 day average volume is 5,292,758. FOLD market cap is 1.94B with 307,930,984 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC